Other primary cancers among Norwegian prostate cancer patients, incidence and risk factors
- Prosjektnummer
- 46055500-17
- Ansvarlig person
- Bjørg Yksnøy Aksnessæther
- Institusjon
- Helse Møre og Romsdal HF
- Prosjektkategori
- Doktorgradsstipend
- Helsekategori
- Cancer
- Forskningsaktivitet
- 6. Treatment Evaluation
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial.
Int J Radiat Oncol Biol Phys 2020 03 15;106(4):706-714. Epub 2019 nov 28
PMID: 31786279 - Inngår i doktorgradsavhandlingen
Second cancers in radically treated Norwegian prostate cancer patients.
Acta Oncol 2019 Jun;58(6):838-844. Epub 2019 mar 25
PMID: 30905229 - Inngår i doktorgradsavhandlingen
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
Int J Radiat Oncol Biol Phys 2018 May 01;101(1):211-216. Epub 2018 feb 5
PMID: 29534900 - Inngår i doktorgradsavhandlingen
Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial.
Clin Transl Radiat Oncol 2018 Nov;13():50-56. Epub 2018 sep 29
PMID: 30364704
Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial.
Radiother Oncol 2018 02;126(2):229-235. Epub 2018 feb 3
PMID: 29398152
Does Prophylactic Radiotherapy to avoid Gynecomastia in Patients with Prostate Cancer increase the risk of Breast Cancer?
Accepted Jan 23 2018. Waiting for publication International Journal of Radiation Oncology
- Jo -Åsmund Lund Hovedveileder
- Bjørg Yksnøy Aksnessæther Doktorgradsstipendiat
- Olbjørn Klepp Medveileder, biveileder
- Solveig Roth Hoff Medveileder, biveileder
- Eva Marie Skovlund Medveileder, biveileder
- Arne Solberg Medveileder, biveileder
- Jo-Åsmund Lund Hovedveileder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU